NCT03315975View on ClinicalTrials.gov

Flu Vaccine Responses in the Setting of Melanoma Treatment

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Viral Vaccines
Interventions
BIOLOGICAL

Inactivated influenza vaccine

One dose of quadrivalent inactivated influenza vaccine

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER